Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets in Healthy Subjects Under Fed Conditions.

NCT07633041 is registered in ClinicalTrials.gov with ADIUM as lead sponsor.

NCT NCT07633041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07633041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets in Healthy Subjects Under Fed Conditions.
Lead sponsor
ADIUM
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2025
Completion date
April 4, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence study in healthy subjects